Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Ella Pickover

HISTORICAL FACTS: Mounjaro weight loss jabs now available from gps | History Defined

  • The NHS in England is set to begin a mass rollout of the anti-obesity drug Mounjaro (tirzepatide) on Monday, with GPs allowed to prescribe it for the first time.
  • The initiative is expected to reach approximately 220,000 severely obese people with multiple health complications across England over the next three years.
  • Eligibility for the drug includes a body mass index (BMI) over 40 and at least four other obesity-linked health problems, such as type 2 diabetes or high blood pressure.
  • Leading family doctors have raised concerns about the additional workload and training implications for GPs associated with the new rollout.
  • Pharmacy experts anticipate potential pressure on drug supplies and say that the medication should be part of a comprehensive weight management strategy, not a standalone solution.

IN FULL

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.